Norgine Ventures Announces Successful Conclusion of its Investment in Innovative Pharma Company Internis
London. 12 January 2015, 09.00 AM GMT. Norgine Ventures today announced that it has successfully exited its investment in Internis Pharmaceuticals Limited following the acquisition of Internis by an undisclosed pharmaceutical company in December 2014. This transaction represents a significant achievement for this exciting and innovative British company. Internis, founded in 2010 by Charles Tannenbaum, […]